Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 16/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 15/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | GLA | P06280 | 2/20 | 0.38 |
| ▸ | PIM1 | P11309 | 1/20 | 0.38 |
| ▸ | RUNX1 | Q01196 | 1/20 | 0.38 |
| ▸ | CBFB | Q13951 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ALPL | P05186 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2172385 | 0.86 | KDM4E (0.39) | KDM4EGLAPIM1ALDH1A1ALPL | |
| SCHEMBL2175786 | 0.78 | KDM4E (0.38) | KDM4EGLAPIM1RUNX1CBFB | |
| SCHEMBL2172245 | 0.78 | TP53 (0.41) | KDM4EALDH1A1ALPLHSD17B10 | |
| SCHEMBL2171240 | 0.77 | KDM4E (0.39) | KDM4EGLAPIM1ALDH1A1ALPL | |
| SCHEMBL2172957 | 0.76 | PIK3CA (0.53) | KDM4EGLAPIM1ALDH1A1ALPL | |
| SCHEMBL2175693 | 0.75 | ALPL (0.41) | KDM4EALDH1A1ALPLHSD17B10 | |
| SCHEMBL2173919 | 0.74 | GPBAR1 (0.44) | KDM4EGLAPIM1ALDH1A1ALPL | |
| SCHEMBL2171308 | 0.74 | PIK3CA (0.53) | KDM4EGLAALDH1A1ALPLHSD17B10 | |
| SCHEMBL2173329 | 0.74 | GPBAR1 (0.47) | KDM4EALDH1A1ALPLHSD17B10 | |
| SCHEMBL2171314 | 0.72 | GPBAR1 (0.47) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346832-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | Glaxo Group Limited (GB) | 2011-07-27 | — | — | EP | claimed |
| WO-2010049366-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | GLAXO GROUP LIMITED (GB) | 2010-05-06 | — | — | WO | claimed |
| EP-2346832-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | Glaxo Group Limited (GB) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010049366-A1 | TRICYCLIC COMPOUNDS AS GLUTAMATE RECEPTOR MODULATORS | GLAXO GROUP LIMITED (GB) | 2010-05-06 | — | — | WO | disclosed |